Table 1 Clinical characteristics of our study population and controls

Age

45,55 ± 10,24

49,89 ± 1,05

0.176

48,58 ± 10,874

50.27 ± 10.254

0.566

Sex M/F

10/5

[66,7%/32,3%]

38/16

[70,4%/27,8%]

0.784

14/7

[66,7%/33,3%]

24/9

[72,7%/27,3%]

0.634

BMI

22,91 ± 2,76

30,17 ± 3,86

<0.001

29,51 ± 3,31

30,6 ± 4,21

0.320

Hypertension

0

21 [38,9%]

0.005

7 [33,3%]

14 [42,4%]

0.521

Diabetes

0

11 [22,2%]

0.057

4 [19,0%]

7 [21,2%]

0.847

Dyslipidemia

0

35 [64,8%]

<0.001

16 [76,2%]

19 [57,6%]

0.163

Obesity

3 [20,00%]

29 [53,7%]

0.021

12 [57,1%]

17 [51,5%]

0.686

Insulin

–

17,65 ± 5,95

–

14,08 ± 2,06

21,18 ± 6,98

<0.001

HOMA

–

4,36 ± 1,72

–

3,10 ± 0,08

5,24 ± 1,58

<0.001

Metabolic Syndrome

0

19 [35,2%]

0.007

7 [33,3%]

12 [36,4%]

0.820

Cirrhosis

0

6 [11,1%]

0.177

0

6 [18,2%]

0.077

ALT

26,44 ± 9,56

67,56 ± 44,37

<0.001

66,00 ± 43,65

68,33 ± 46,64

0.085